Prot #GAO4753g: An Open-Label, Multicenter, Randomized, Phase III Study To Investigate The Efficacy And Safety of Bendamustine Compared With Bendamustine + RO5072759 (GA101) In Patients With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma

Project: Research project

Project Details

StatusFinished
Effective start/end date1/28/13 → 1/28/19

Funding

  • INC Research, LLC (Prot #GAO4753g // Prot #GAO4753g)
  • Genentech, Inc (Prot #GAO4753g // Prot #GAO4753g)